Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for freezing of gait in Parkinson's disease
NL-OMON23006Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of methylphenidate in Parkinson's disease (PD) (4 arms), sponsored by University Medical Center Groningen. Primary endpoints: Behavioral task performance comparison, Cerebral activation during response shifting and 2 more. Started Sep 2010; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON23006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23006.